Back to Search
Start Over
The Prevalence and Burden of Non-AIDS Comorbidities Among Women Living With or at Risk for Human Immunodeficiency Virus Infection in the United States.
- Source :
- Clinical Infectious Diseases; 4/15/2021, Vol. 72 Issue 8, p1301-1311, 11p
- Publication Year :
- 2021
-
Abstract
- Background The prevalence and burden of age-related non-AIDS comorbidities (NACMs) are poorly characterized among women living with HIV (WLWH). Methods Virologically suppressed WLWH and HIV-seronegative participants followed in the Women's Interagency HIV Study (WIHS) through at least 2009 (when >80% of WLWH used antiretroviral therapy) were included, with outcomes measured through 31 March 2018. Covariates, NACM number, and prevalence were summarized at most recent WIHS visit. We used linear regression models to determine NACM burden by HIV serostatus and age. Results Among 3232 women (2309 WLWH, 923 HIV-seronegative) with median observation of 15.3 years, median age and body mass index (BMI) were 50 years and 30 kg/m<superscript>2</superscript>, respectively; 65% were black; 70% ever used cigarettes. WLWH had a higher mean NACM number than HIV-seronegative women (3.6 vs 3.0, P < .0001) and higher prevalence of psychiatric illness, dyslipidemia, non-AIDS cancer, kidney, liver, and bone disease (all P < .01). Prevalent hypertension, diabetes, and cardiovascular and lung disease did not differ by HIV serostatus. Estimated NACM burden was higher among WLWH versus HIV-seronegative women in those aged 40–49 (P < .0001) and ≥60 years (P = .0009) (HIV × age interaction, P = .0978). In adjusted analyses, NACM burden was associated with HIV, age, race, income, BMI, alcohol abstinence, cigarette, and crack/cocaine use; in WLWH, additional HIV-specific indices were not associated, aside from recent abacavir use. Conclusions Overall, NACM burden was high in the cohort, but higher in WLWH and in certain age groups. Non-HIV traditional risk factors were significantly associated with NACM burden in WLWH and should be prioritized in clinical guidelines for screening and intervention to mitigate comorbidity burden in this high-risk population. [ABSTRACT FROM AUTHOR]
- Subjects :
- HIV infection epidemiology
COMORBIDITY
HIV infection complications
HIV infection risk factors
MENTAL illness risk factors
KIDNEY disease risk factors
HIV-positive persons
HIV seronegativity
HIV infections
BONE diseases
AGE distribution
BLACK people
ANTIRETROVIRAL agents
RACE
REGRESSION analysis
RISK assessment
HYPERLIPIDEMIA
LIVER diseases
SEX distribution
INCOME
DESCRIPTIVE statistics
DISEASE prevalence
COCAINE
TOBACCO products
BODY mass index
STATISTICAL models
WOMEN'S health
AIDS
DISEASE risk factors
Subjects
Details
- Language :
- English
- ISSN :
- 10584838
- Volume :
- 72
- Issue :
- 8
- Database :
- Complementary Index
- Journal :
- Clinical Infectious Diseases
- Publication Type :
- Academic Journal
- Accession number :
- 150005122
- Full Text :
- https://doi.org/10.1093/cid/ciaa204